A clinical literature review and research-trends analysis of bee venom pharmacopuncture for cancer patients

Joo-Hee Kim; Kim, Joo-Hee

doi:10.13048/jkm.20038

JKM > Volume 41(3); 2020 > Article

Kim: A clinical literature review and research-trends analysis of bee venom pharmacopuncture for cancer patients

Reviewe Article

The Journal of Korean Medicine 2020; 41(3): 247-259.

Published online: September 01, 2020

DOI: https://doi.org/10.13048/jkm.20038

A clinical literature review and research-trends analysis of bee venom pharmacopuncture for cancer patients

Joo-Hee Kim^*

Department of Acupuncture and Moxibustion Medicine, College of Korean Medicine, Sangji University, Research Institute of Korean Medicine, Sangji Univeristy

Correspondence to: Joo-Hee Kim Department of Acupuncture and Moxibustion Medicine, College of Korean Medicine, Sangji University 83, Sangjidae-gil, Wonju-si, Gangwon-do, 26339, Republic of Korea, Tel: +82-33-742-9268, Fax: +82-33-732-2124, Email: jhkim712@sangji.ac.kr

Received August 06, 2020 Revised August 13, 2020 Accepted August 14, 2020

Abstract

Objectives

This review aims to investigate clinical studies related to bee venom pharmacopuncture for cancer patients and to analyze the research trend for further study.

Methods

We searched for clinical studies using bee venom pharmacopuncture therapy on patients with cancer through the electronic databases including Pubmed, Cochrane library, OASIS, KISS, NDSL, and KMBASE. There was no restriction on language and publication date, and after selection/exclusion process, the study design, target disease, intervention details including acupoints, treatment frequency and period, outcomes, study results and adverse events were extracted.

Results

Thirteen clinical studies were finally selected. There were a randomized controlled trial RCT about the effect of sweet bee venom pharmacopuncture on cancer-related pain, and three case series about chemotherapy-induced peripheral neuropathy. In case reports, there were nine studies about oligodendroglioma, plexiform neurofibroma, breast cancer, prostate cancer, lung cancer, urachal adenocarcinoma, malignant melanoma, and atypical squamous cells of undetermined significance. The bee venom therapy affected the improvement of outcomes such as symptoms, quality of life, tumor response, and lab findings.

Conclusions

The present study found that bee venom therapy is applicable to the treatment of cancer patients, and showed some effect on various symptoms. However, due to insufficient number and quality of studies, well designed and high-quality clinical trials are necessary to confirm the effectiveness and safety of bee venom pharmacopuncture therapy in patients with cancer.

Keywords: Cancer, Neoplasm, Bee venom, Pharmacopuncture, Clinical research, Review

Acknowledgments

This research was supported by Sangji University Research Fund, 2018. I thanks to my medical student Hyeon-Jong Yoo for performing study selection and data extraction.

Fig. 1

Study flow chart

Table 1

Characteristics of the Included Studies

Author, year	Study design	Patients (n)	Interventions (n)	Acupoint/Dosage	Frequency of Treatment	Concomitant treatment	Outcomes	Results	Adverse events (n)
Yoo et al., 200830)	RCT	Patients with cancer-related pain (11)	TG: SBV (6), 0.1mg/ml CG: Placebo (5), normal saline	CV12/1ml	daily for five days	-	1. NRS 1) immediate pain relief 2) long term	1. 1) T>C (p<0.05) 2) NS	NR
Kim et al., 201831)	Case report	Breast cancer patient with chemotherapy-induced Side effects (1)	nBV	ST36, ST35, ST34, GB34, Ashi/0.2–0.4cc each point	3 times/week, total 10 session	AT, MT, HM PA(CWG, TC)	1. CTCAE 2. ECOG	Improved	NR
Kim et al., 2015 41)	Case report	Oligodendroglioma (1)	BV	GV20, EX-HN1/0.2 mL each point	once weekly for 18 months	ATX, HM, PA(MG)	1. Tumor size (Brain MRI) 2. Symptoms 3. Survival	1. decreased markedly 2. improved symptoms	NR
Lim et al., 201433)	Case report	Plexiform neurofibroma (1)	SBV, intracutaneously	the borders of the PNFs/5 mL	every two weeks for 4 years	PA(MG)	1. Tumor response (MRI) 2. Symptoms (hip joint pain, ROM)	1. the growths of the PNFs have almost stopped 2. improved symptoms	NR
Park et al., 201432)	Case series	CIPN (4)	BV, Ointment	Hand and/or foot	1–2 times/day	-	1. VAS	1. improved	None
Yoon et al., 201234)	Case series	CIPN (11)	SBV, 0.1 cun	LI4, TE5, GB39, LR3/0.1 ml each point	Total 6 session for 3 weeks	-	1. WHO grading system, 2. PNQ 3. VAS 4. HRQOL	1. improved (p<0.01) 2. improved (p<0.05) 3. improved (p<0.01) 1. improved (p<0.01)	swelling and itchiness at the injection site (1) mild fever (1)
Park et al., 201240)	Case series	CIPN (5)	SBV, Melittin of 0.1 mg/mL, 0.1 cm	EX-LE10, EX-UE9/0.1 ml each point	3 sessions over a 1-week period	-	1. VAS: pain 2. WHO CIPN grade 3. FACT-G	1. improved: 8.75 –> 2.75 2. improved: 2.5–>1 3. improvedin physical section: 10.5–>18.5	None
Lee et al., 201142)	Case report	Prostate cancer patients (2)	SBV	CV12, CV6/0.3ml each point, LI4, LR3, ST36, CV3, SP6, CV1/0.1 ml each point	2–5 times/week	AT, PA(MG)	1. PSA	1. decreased	NR
Gu et al., 201143)	Case report	Lung Cancer Patient (1)	SBV, 10%	BL13, Ashi/0.4–0.6ml	3 times/week	AT, MT, cupping, HM, breathing meditation	1. BDI 2. HRSD 3. BAI 4. ASI	1. decreased 2. decreased 3. decreased 4. decreased	NR
Choi et al., 201144)	Case report	Urachal Adenocarcinoma Patient (1)	SBV	LI4, LR3/0.1ml each point, BL20, BL21/0.25ml each point	2–3 times/week	AT, HM	1. Symptoms 2. Lab finding	1. Stable 2. Stable	NR
Park et al., 201045)	Case report	lung adenocarcinoma (1)	BV	CV12, GV3	every 2 days	AT, MT, cupping, HM, PA(placenta), Massage, TENS, Hydrotherapy (hip bath and foot bath), meditation, exercise	1. Symptoms: exertional dyspnea with thoracic pain and pain in both upper limbs, emotional stress	1. improved disease-free survival of 28 months	NR
Bang et al., 200746)	Case report	Malignant melanoma (1)	BV, 10000:1	Lesion, 1.5ml	Once a day for 1 year	-	1. Tumor response (PET CT, Neck CT)	1. Stable disease	None
Kim et al., 200547)	Case report	ASCUS (2)	BV	Lesion, SC 0.2–0.6ml	Once a week, total 12 session	-	1. Pap smear 2. HPV test 3. Cervical biopsy	1. negative 2. negative 3. (1) Immature metaplasia→Squamous metaplasia (2) Squamous metaplasia→Koilocytotic change	None

SBV, Sweet Bee Venom; NRS, Numerical Rating Scale; NR, not reported; NS, non-statistically significant; nBV, non-toxic Bee Venom; CWG, Cultivated Wild Ginseng; TC, Trionycis Carapax; Common Toxicity Criteria for Adverse Event, CTCAE; ECOG, Eastern Cooperative Oncology Group; MG, mountain ginseng; ROM, range of motion; CIPN, chemotherapy-induced peripheral neuropathy; PNQ, Patient Neurotoxicity Questionnaire; HRQOL, Health-Related Quality of Life; FACT-G, Functional Assessment of Cancer Therapy-General; PSA, Prostate specific antigen; BDI, Beck’s depression inventory; HRSD, Hamilton rating scale for depression; BAI, Beck’s anxiety inventory; ASI, Anxiety status inventory; ASCUS, Atypical squamous cells of undetermined significance; HPV, human papilloma virus; SC, subcutaneous; AT, acupuncture; HM, herbal medicine; MT: Moxibustion; PA, pharmacopuncture; TENS, Transcutaneous Electrical Nerve Stimulation,

참고문헌

1. National cancer information center. Cancer prevalence rates. Available from: URL: https://www.cancer.go.kr/lay1/S1T654C655/contents.do

2. Towler, P, Molassiotis, A, & Brearley, S. What is the evidence for the use of acupuncture as an intervention for symptom management in cancer supportive and palliative care: an integrative overview of reviews. Supportive Care in Cancer, (2013). 21(10), 2913-23.

3. Bao, T, Patil, S, Chen, C, Zhi, IW, Li, QS, & Piulson, L, et al. Effect of Acupuncture vs Sham Procedure on Chemotherapy-Induced Peripheral Neuropathy Symptoms: A Randomized Clinical Trial. JAMA Netw Open, (2020). 3(3), e200681.

4. Garcia, MK, Meng, Z, Rosenthal, DI, Shen, Y, Chambers, M, & Yang, P, et al. Effect of True and Sham Acupuncture on Radiation-Induced Xerostomia Among Patients With Head and Neck Cancer: A Randomized Clinical Trial. JAMA Netw Open, (2019). 2(12), e1916910.

5. Jin, H, Xiang, Y, Feng, Y, Zhang, Y, Liu, S, & Ruan, S, et al. Effectiveness and Safety of Acupuncture Moxibustion Therapy Used in Breast Cancer-Related Lymphedema: A Systematic Review and Meta-Analysis. Evidence-based complementary and alternative medicine. eCAM, (2020). 2020, 3237451.

6. Lu, W, Giobbie-Hurder, A, Freedman, RA, Shin, IH, Lin, NU, & Partridge, AH, et al. Acupuncture for Chemotherapy-Induced Peripheral Neuropathy in Breast Cancer Survivors: A Randomized Controlled Pilot Trial. The oncologist, (2020). 25(4), 310-8.

7. Hershman, DL, Unger, JM, Greenlee, H, Capodice, JL, Lew, DL, & Darke, AK, et al. Effect of Acupuncture vs Sham Acupuncture or Waitlist Control on Joint Pain Related to Aromatase Inhibitors Among Women With Early-Stage Breast Cancer: A Randomized Clinical Trial. Jama, (2018). 320(2), 167-76.

8. Park, JM, You, SJ, Choi, SY, Moon, G, & Lyu, YS. Survey of Motives for Visiting Oriental Medical Hospital and Satisfaction with Oriental Medical Care for Cancer Patients: Report of 22 Cases. J of Oriental Neuropsychiatry, (2015). 26(1), 23-38.

9. Committee KAMSTC. Acupuncture Medicine. Seoul. Hanmi medicine;(2020.

10. Kim, J, & Kang, DI. A descriptive statistical approach to the Korean pharmacopuncture therapy. J Acupunct Meridian Stud, (2010). 3(3), 141-9.

11. Son, DJ, Lee, JW, Lee, YH, Song, HS, Lee, CK, & Hong, JT. Therapeutic application of anti-arthritis, pain-releasing, and anti-cancer effects of bee venom and its constituent compounds. Pharmacology & therapeutics, (2007). 115(2), 246-70.

12. Zheng, J, Lee, HL, Ham, YW, Song, HS, Song, MJ, & Hong, JT. Anti-cancer effect of bee venom on colon cancer cell growth by activation of death receptors and inhibition of nuclear factor kappa B. Oncotarget, (2015). 6(42), 44437-51.

13. pSW, , Liao, SS, Lin, SY, Lin, JP, Yang, JS, & Lin, ML, et al. The role of mitochondria in bee venom-induced apoptosis in human breast cancer MCF7 cells. In vivo (Athens, Greece), (2008). 22(2), 237-45.

14. Kim, DH, Lee, HW, Park, HW, Lee, HW, & Chun, KH. Bee venom inhibits the proliferation and migration of cervical-cancer cells in an HPV E6/E7-dependent manner. BMB reports, (2020.

15. Lee, HL, Park, SH, Kim, TM, Jung, YY, Park, MH, & Oh, SH, et al. Bee venom inhibits growth of human cervical tumors in mice. Oncotarget, (2015). 6(9), 7280-92.

16. Kim, YW, Chaturvedi, PK, Chun, SN, Lee, YG, & Ahn, WS. Honeybee venom possesses anticancer and antiviral effects by differential inhibition of HPV E6 and E7 expression on cervical cancer cell line. Oncology reports, (2015). 33(4), 1675-82.

17. Jo, M, Park, MH, Kollipara, PS, An, BJ, Song, HS, & Han, SB, et al. Anti-cancer effect of bee venom toxin and melittin in ovarian cancer cells through induction of death receptors and inhibition of JAK2/STAT3 pathway. Toxicology and applied pharmacology, (2012). 258(1), 72-81.

18. Han, G, Shin, H, Seong, S, & Kim, S. Systematic Review of Case Reports about Korean Medicine for Lung Cancer. J Korean Med, (2018). 39(4), 136-57.

19. Jeong, YJ, Park, YY, Park, KK, Choi, YH, Kim, CH, & Chang, YC. Bee Venom Suppresses EGF-Induced Epithelial-Mesenchymal Transition and Tumor Invasion in Lung Cancer Cells. The American journal of Chinese medicine, (2019). 47(8), 1869-83.

20. Liu, S, Yu, M, He, Y, Xiao, L, Wang, F, & Song, C, et al. Melittin prevents liver cancer cell metastasis through inhibition of the Rac1-dependent pathway. Hepatology, (2008). 47(6), 1964-73.

21. Wang, X, Li, H, Lu, X, Wen, C, Huo, Z, & Shi, M, et al. Melittin-induced long non-coding RNA NONHSAT105177 inhibits proliferation and migration of pancreatic ductal adenocarcinoma. Cell death & disease, (2018). 9(10), 940.

22. Park, MH, Choi, MS, Kwak, DH, Oh, KW, Yoon, DY, & Han, SB, et al. Anti-cancer effect of bee venom in prostate cancer cells through activation of caspase pathway via inactivation of NF-κB. The Prostate, (2011). 71(8), 801-12.

23. Ip, SW, Chu, YL, Yu, CS, Chen, PY, Ho, HC, & Yang, JS, et al. Bee venom induces apoptosis through intracellular Ca2+-modulated intrinsic death pathway in human bladder cancer cells. International journal of urology : official journal of the Japanese Urological Association, (2012). 19(1), 61-70.

24. Ryu, HK, Baek, YH, Park, YC, & Seo, BK. Current studies of acupuncture in cancer-induced bone pain animal models. Evidence-based complementary and alternative medicine : eCAM, (2014). 2014, 191347.

25. Choi, S, Chae, HK, Heo, H, Hahm, DH, Kim, W, & Kim, SK. Analgesic Effect of Melittin on Oxaliplatin-Induced Peripheral Neuropathy in Rats. Toxins, (2019). 11(7),

26. Yun, HS, Lee, JD, & Lee, YH. Systemic Review: The Study on Bee Venom Related to Cancer in PubMed. J Acupunct Res, (2000). 17(4), 69-78.

27. Han, CH, Lee, YS, Kwon, OM, & Lee, YJ. The Review on the Study of Bee Venom in the Journals of Korean Medicine. Korean Journal of Acupuncture, (2013). 30(1), 27-36.

28. Han, C, Lee, Y, Sung, S, Lee, B, Shin, H, & Lee, Y. Trend Analysis of the Research on Bee Venom Acupuncture in South Korea, Based on Published Articles. J Korean Med, (2015). 36(4), 80-103.

29. Cheon, S, Zhang, X, Lee, IS, Cho, SH, Chae, Y, & Lee, H. Pharmacopuncture for cancer care: a systematic review. Evid Based Complement Alternat Med, (2014). 2014(12), 804746.

30. Yoo, H, & Kim, J. The Effect of Sweet Bee Venom Pharmacopuncture(SBVP) on Cancer -Related Pain : A Randomized Controlled Trial and Double Blinded - Pilot study. Journal of Pharmacopuncture, (2008). 11(1), 21-9.

31. Kim, M, Jung, Y, & Hong, S. A Case Report of Cyclophosphamide plus Doxorubicin-induced Side effects in Patient with Both Sides Breast Cancer Treated with Integrative Medicine Therapy Including Pharmacopuncture. J of Kor Traditional Oncology, (2018). 23(1), 33-43.

32. Park, B, Kim, J, Cho, C, Shin, S, & Yoo, H. Effect of Bee Venom Ointment Treatment for Chemotherapy-induced Peripheral Neuropathy : A Case Series. (2014). 22(2), 111-7.

33. Lim, C, Kwon, K, & Lee, K. Plexiform Neurofibroma Treated with Pharmacopuncture. Journal of Pharmacopuncture, (2014). 17(3), 74-7.

34. Yoon, J, Jeon, JH, Lee, YW, Cho, CK, Kwon, KR, & Shin, JE, et al. Sweet Bee Venom Pharmacopuncture for Chemotherapy-Induced Peripheral Neuropathy. Journal of Acupuncture and Meridian Studies, (2012). 5(4), 156-65.

35. Oršolić, N. Bee venom in cancer therapy. Cancer and metastasis reviews, (2012). 31(1), 173-94.

36. Ma, R, Mahadevappa, R, & Kwok, HF. Venom-based peptide therapy: insights into anti-cancer mechanism. Oncotarget, (2017). 8(59), 100908-30.

37. Park, JH, Jeong, YJ, Park, KK, Cho, HJ, Chung, IK, & Min, KS, et al. Melittin suppresses PMA-induced tumor cell invasion by inhibiting NF-kappaB and AP-1-dependent MMP-9 expression. Molecules and cells, (2010). 29(2), 209-15.

38. Cornara, L, Biagi, M, Xiao, J, & Burlando, B. Therapeutic Properties of Bioactive Compounds from Different Honeybee Products. Frontiers in pharmacology, (2017). 8, 412.

39. Lazdunski, M, Fosset, M, Hughes, M, Mourre, C, & Romey, G. Schmid-Antomarchi H, The apamin-sensitive Ca2+-dependent K+ channel molecular properties, differentiation and endogenous ligands in mammalian brain. Biochemical Society symposium, (1985). 50, 31-42.

40. Park, JW, Jeon, JH, Yoon, J, Jung, TY, Kwon, KR, & Cho, CK, et al. Effects of sweet bee venom pharmacopuncture treatment for chemotherapy-induced peripheral neuropathy: a case series. Integrative cancer therapies, (2012). 11(2), 166-71.

41. Kim, JS, Lee, HJ, Lee, SH, & Lee, BH. Recurrent Oligodendroglioma Treated with Acupuncture and Pharmacopuncture. Journal of Acupuncture and Meridian Studies, (2015). 8(3), 147-51.

42. Lee, Y, Kim, C, & Lee, K. A case report of monitoring PSA level changes in two prostate cancer patients treated with Mountain Ginseng Pharmacopuncture and Sweet Bee Venom along with western anticancer therapy. Journal of Pharmacopuncture, (2011). 14(4), 81-8.

43. Gu, JH, Kim, SR, Im, EY, Kim, SH, & Kim, JD. One Clinical Case Report of Lung Cancer Patient with Depression and Anxiety Disorder Improved by Korean Traditional Medical Treatment and Breathing Meditation. Korean J Oriental Physiology & Pathology, (2011). 25(6), 1102-7.

44. Choi, J, Cho, C, Lee, Y, & Yoo, H. A Case of Urachal Adenocarcinoma Patient Treated with Oriental Medicine. J of Kor Traditional Oncology, (2011). 16(2), 53-61.

45. Park, HM, Kim, SY, Jung, IC, Lee, YW, Cho, CK, & Yoo, HS. Integrative tumor board: a case report and discussion from East-West Cancer Center. Integr Cancer Ther, (2010). 9(2), 236-45.

46. Bang, SH, & Yoo, HS. A Case Report on the Patient of Malignant Melanoma at Right Maxilla with the Treatment of Bee Venom Phamacopuncture. Journal of Pharmacopuncture, (2007). 10(2), 99-105.

47. Kim, SW, Zhang, KH, Yi, YJ, Kim, BN, & Kim, SH. A report of Atypical squamous cells of undetermined significance(ASCUS) treated by Bee Venom Therapy. The Journal of Oriental Obstetrics & Gynecology, (2005). 18(2), 169-75.